{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:27:33Z","timestamp":1794486453953,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007028","name":"The Leona M and Harry B Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis US LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eprac.2026.10.003","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:12:25Z","timestamp":1792228345000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Real-World Beta-Cell Preservation Framework in Type 1 Diabetes: Consensus From the T1D Exchange (T1DX-QI)"],"prefix":"10.1016","author":[{"given":"Carla","family":"Demeterco-Berggren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4964-7716","authenticated-orcid":false,"given":"David T.","family":"Broome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Todd","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Sherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"DeSalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimber","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Culbreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava K.","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Gelick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Lonier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi R.","family":"Fogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"McCauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abha","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeniece","family":"Ilkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Pat","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shideh","family":"Majidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Holly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Rainey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Rioles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevon","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5144-7836","authenticated-orcid":false,"given":"Laura M.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Supplement_1","key":"10.1016\/j.eprac.2026.10.003_bib1","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc26-S002","article-title":"Diagnosis and classification of diabetes: standards of care in Diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2026.10.003_bib2","first-page":"1276","article-title":"Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes","volume":"47","author":"Phillip","year":"2024","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2026.10.003_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1159\/000543035","article-title":"ISPAD Clinical Practice Consensus Guidelines 2024: screening, staging, and strategies to preserve beta-cell function in children and adolescents with type 1 diabetes","volume":"97","author":"Haller","year":"2024","journal-title":"Horm Res Paediatr"},{"issue":"23","key":"10.1016\/j.eprac.2026.10.003_bib4","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.eprac.2026.10.003_bib5","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00125-013-2850-z","article-title":"Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels","volume":"56","author":"Fredheim","year":"2013","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.eprac.2026.10.003_bib6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1399-5448.2011.00829.x","article-title":"Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies","volume":"13","author":"Winkler","year":"2012","journal-title":"Pediatr Diabetes"},{"issue":"9","key":"10.1016\/j.eprac.2026.10.003_bib7","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00125-023-05953-0","article-title":"Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation","volume":"66","author":"Hummel","year":"2023","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.eprac.2026.10.003_bib8","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s00125-023-06017-z","article-title":"Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al [letter]","volume":"66","author":"Hummel","year":"2023","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.eprac.2026.10.003_bib9","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s00125-023-05999-0","article-title":"Presymptomatic type 1 diabetes and disease severity at onset","volume":"66","author":"Schneider","year":"2023","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.eprac.2026.10.003_bib10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/dc17-0558","article-title":"Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor long-term glycemic control","volume":"40","author":"Duca","year":"2017","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2026.10.003_bib11","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1210\/clinem\/dgae158","article-title":"Lower prevalence of diabetic ketoacidosis at diagnosis in research participants monitored for hyperglycemia","volume":"110","author":"Sooy","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2026.10.003_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jama.2019.21565","article-title":"Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany","volume":"323","author":"Ziegler","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.eprac.2026.10.003_bib13","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/diacare.27.6.1399","article-title":"Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up","volume":"27","author":"Barker","year":"2004","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2026.10.003_bib14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/pedi.12541","article-title":"Ketoacidosis at diagnosis of type 1 diabetes: effect of prospective studies with newborn genetic screening and follow up of risk children","volume":"19","author":"Hekkala","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"10.1016\/j.eprac.2026.10.003_bib15","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-048942","article-title":"Hemoglobin A1c patterns of youth with type 1 diabetes 10 years post diagnosis from 3 continents","volume":"148","author":"Sherr","year":"2021","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.eprac.2026.10.003_bib16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An Anti-CD3 antibody, Teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.eprac.2026.10.003_bib17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2337\/db13-0881","article-title":"Impact of C-peptide preservation on metabolic and clinical outcomes in the diabetes control and complications Trial","volume":"63","author":"Lachin","year":"2014","journal-title":"Diabetes"},{"issue":"Suppl 6","key":"10.1016\/j.eprac.2026.10.003_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/dom.16522","article-title":"Health economic considerations of screening for early type 1 diabetes","volume":"27","author":"Rewers","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.eprac.2026.10.003_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/cd19-0032","article-title":"Establishment of the T1D exchange quality improvement collaborative (T1DX-QI)","volume":"38","author":"Alonso","year":"2020","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.eprac.2026.10.003_bib20","author":"Demeterco-Berggren"},{"issue":"8260-61","key":"10.1016\/j.eprac.2026.10.003_bib21","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(81)92795-1","article-title":"Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus","volume":"2","author":"Gorsuch","year":"1981","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2026.10.003_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0896-8411(09)90009-9","article-title":"Comparison of islet autoantibodies in 'pre-diabetes' and recommendations","volume":"3","author":"Riley","year":"1990","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.eprac.2026.10.003_bib23","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2337\/dc24-2908","article-title":"Type 1 diabetes TrialNet: leading the charge in disease prediction, prevention, and immunotherapeutic mechanistic understanding","volume":"48","author":"Jacobsen","year":"2025","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2026.10.003_bib24","first-page":"S12","article-title":"Standards of medical care in diabetes--2008","volume":"31","year":"2008","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2026.10.003_bib25","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2026.10.003_bib26","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.2337\/dc23-S003","article-title":"3. Prevention or delay of type 2 diabetes and associated comorbidities: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eprac.2026.10.003_bib27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ecl.2010.05.007","article-title":"Advances in the prediction and natural history of type 1 diabetes","volume":"39","author":"Bonifacio","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"7","key":"10.1016\/j.eprac.2026.10.003_bib28","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2337\/dc14-1140","article-title":"Type 1 diabetes Sourcebook A. Type 1 diabetes through the life span: a position statement of the American Diabetes Association","volume":"37","author":"Chiang","year":"2014","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2026.10.003_bib29","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1111\/dom.16454","article-title":"Risk of new-onset type 1 diabetes in individuals with celiac disease and thyroid diseaes-An observational study","volume":"27","author":"Edelman","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"1 Suppl 1","key":"10.1016\/j.eprac.2026.10.003_bib30","first-page":"S27","article-title":"Diagnosis and classification of diabetes: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2026.10.003_bib31","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.2337\/dci21-0043","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"44","author":"Holt","year":"2021","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2026.10.003_bib32","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1210\/clinem\/dgaf194","article-title":"Establishing screening programs for presymptomatic type 1 diabetes: practical guidance for diabetes care providers","volume":"110","author":"Leichter","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2026.10.003_bib33","first-page":"281","article-title":"Principles and practice of mass screening for disease","volume":"65","author":"Wilson","year":"1968","journal-title":"Bol Oficina Sanit Panam"},{"issue":"2","key":"10.1016\/j.eprac.2026.10.003_bib34","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00125-025-06586-1","article-title":"Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes","volume":"69","author":"Gitelman","year":"2026","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.eprac.2026.10.003_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/dia.2025.0028","article-title":"A call-to-action to eliminate barriers to accessing automated insulin delivery systems for people with type 1 diabetes","volume":"27","author":"Saboo","year":"2025","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"10.1016\/j.eprac.2026.10.003_bib36","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.4239\/wjd.v15.i10.2022","article-title":"Immunotherapy in type 1 diabetes: novel pathway to the future ahead","volume":"15","author":"Ray","year":"2024","journal-title":"World J Diabetes"},{"issue":"12","key":"10.1016\/j.eprac.2026.10.003_bib37","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/dme.14314","article-title":"Characteristics of adult- compared to childhood-onset type 1 diabetes","volume":"37","author":"Casu","year":"2020","journal-title":"Diabet Med"},{"issue":"12","key":"10.1016\/j.eprac.2026.10.003_bib38","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s40273-020-00962-y","article-title":"Cost effectiveness of teplizumab for prevention of type 1 diabetes among different target patient groups","volume":"38","author":"Mital","year":"2020","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.eprac.2026.10.003_bib39","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/dom.16246","article-title":"Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes","volume":"27","author":"O'Donnell","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.eprac.2026.10.003_bib40","first-page":"597","article-title":"Pediatric endocrine Society statement on considerations for use of Teplizumab (Tzield) in clinical practice","volume":"98","author":"Tonyushkina","year":"2025","journal-title":"Horm Res Paediatr"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26012851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26012851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:13:04Z","timestamp":1794485584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26012851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":40,"alternative-id":["S1530891X26012851"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.10.003","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Real-World Beta-Cell Preservation Framework in Type 1 Diabetes: Consensus From the T1D Exchange (T1DX-QI)","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}